Medical Cannabis Research

The following research is found on the National Institute of Health (NIH) website. The NIH is our federal government agency tasked with developing and providing the latest health related peer-reviewed studies.  As of November 20, 2013 there were 17,199 studies available on Cannabis.

Anti-Tumor Effects

NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies).

Cannabinoids and cancer: pros and cons of an antitumour strategy.

Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.

Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1.

Towards the use of cannabinoids as antitumour agents.

A combined preclinical therapy of cannabinoids and temozolomide against glioma.

Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.

Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.

Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion.

Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy.

Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer.

Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo.

Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway.

Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response.

The endogenous cannabinoid system protects against colonic inflammation.

Cannabinoids and cancer: potential for colorectal cancer therapy.

Cannabis-derived substances in cancer therapy--an emerging anti-inflammatory role for the cannabinoids.

Update on the endocannabinoid system as an anticancer target.

Cannabinoids for cancer treatment: progress and promise.

Cannabinoids in the treatment of cancer.